GT BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.12 USD | -4.59% |
|
-6.17% | -59.22% |
| 03-26 | GT Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-01 | GT Biopharma to Conduct 1-for-30 Reverse Stock Split; Shares Fall | MT |
Chart calendar GT Biopharma, Inc.
41f43464195fdbd629300.lNU7CxTHf6TbFoTf2dLBWxhoX_svb1pVi_GeU87nBaU.xZpKYXKkKtCvWeO0t4GDPlYCC5F6KGhhx7XsKZfUWsvMnXxdI68Rl591tA~850e4875494e831244911f6b81362b5c
Upcoming events on GT Biopharma, Inc.
Past events on GT Biopharma, Inc.
| 15/05/2024 22:00 | Q1 2024 Earnings Release |
| 18/12/2023 19:00 | Extraordinary Shareholders Meeting |
| 05/11/2023 02:00 | Society for Immunotherapy of Cancer Meeting - Abstract No:1180 |
| 04/11/2023 18:55 | Society for Immunotherapy of Cancer Meeting - Abstract No:1180 |
| 01/11/2023 13:00 | Q3 2023 Earnings Release |
| 17/08/2023 20:30 | H.C. Wainwright Immune Cell Engager Conference |
| 07/08/2023 14:00 | Q2 2023 Earnings Release |
| 28/06/2023 19:00 | Annual General Meeting |
| 24/05/2023 | ASTCT EBMT Joint Basic and Translational Scientific Meeting |
| 16/05/2023 14:00 | PEGS Boston Conference |
| 15/05/2023 22:00 | Q1 2023 Earnings Release |
| 30/03/2023 22:00 | Q4 2022 Earnings Release |
| 28/02/2023 14:00 | H.C. Wainwright Cell Therapy Virtual Conference |
| 12/12/2022 23:00 | American Society of Hematology Meeting - Abstract Number: 4623 |
| 11/11/2022 14:00 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1204 |
| 11/11/2022 14:00 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1202 |
| 31/10/2022 21:15 | Q3 2022 Earnings Release |
| 27/10/2022 00:30 | LD Micro Main Event Conference |
| 10/10/2022 19:00 | Extraordinary Shareholders Meeting |
| 27/09/2022 | Extraordinary Shareholders Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -6,76 -6,10 -10.89% | -57,5 -46,2 -24.59% | -21,3 -21,2 -0.2% | -13,6 -13,9 2.65% | -17,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -28,3 -16,9 -67.12% | -58,0 -46,6 -24.61% | -20,9 -21,5 2.87% | -7,60 -8,17 7.04% | -17,4 |
|
Net income Million USD | Released Forecast Spread | -38,6 | -28,3 -16,9 -67.12% | -58,0 -46,3 -25.2% | -20,9 -21,5 3% | -7,60 -8,17 7.04% | -17,4 |
|
EPS USD | Released Forecast Spread | -342 | -194 -6,75 -2766.67% | -61,8 -49,4 -25.1% | -19,8 -20,1 1.49% | -5,64 -6,00 6% | -10,8 |
| Announcement Date | 27/03/20 | 16/04/21 | 28/03/22 | 30/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,44 -7,45 26.95% | -3,01 -5,96 49.4% | -7,02 -3,83 -83.15% | -5,78 -5,73 -0.93% | -3,67 -5,70 35.7% | -3,62 -4,15 12.75% | -3,12 -3,95 20.96% | -3,17 -3,54 10.43% | -3,09 -3,88 20.38% | -4,21 | -4,52 | -4,81 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,44 -7,33 25.82% | -2,98 -5,93 49.76% | -6,88 -3,77 -82.4% | -5,58 -6,23 10.35% | -0,23 -6,00 96.22% | -1,99 -4,10 51.41% | -2,42 -3,95 38.84% | -2,96 -3,54 16.26% | -2,27 -3,88 41.63% | -4,21 | -4,52 | -4,81 |
|
Net income Million USD | Released Forecast Spread | -5,44 -7,33 25.82% | -2,98 -5,93 49.76% | -6,88 -3,77 -82.4% | -5,58 -6,23 10.35% | -0,23 -6,00 96.22% | -1,99 -4,10 51.41% | -2,42 -3,95 38.84% | -2,96 -3,54 16.26% | -2,27 -3,88 41.63% | -4,21 | -4,52 | -4,81 |
|
EPS USD | Released Forecast Spread | -5,10 -6,90 26.09% | -3,00 -5,40 44.44% | -6,60 -3,30 -100% | -5,40 -5,70 5.26% | -0,30 -4,80 93.75% | -1,50 -3,00 50% | -1,80 -3,00 40% | -5,52 -2,70 -104.44% | -1,64 -2,70 39.26% | -2,70 | -2,70 | -3,00 |
| Announcement Date | 16/05/22 | 15/08/22 | 31/10/22 | 30/03/23 | 15/05/23 | 07/08/23 | 01/11/23 | 26/03/24 | 15/05/24 | - | - | - |
More events
Past sector events for GT Biopharma, Inc.
| 17/05/2024 13:52 | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 17/05/2024 09:28 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 15:05 | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 06:30 | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 15/05/2024 12:40 | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 15/05/2024 08:03 | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 14/05/2024 22:43 | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 09:52 | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 14/05/2024 06:30 | BAYER AG: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GTBP Stock
- Calendar GT Biopharma, Inc.
